It’s time to talk.
If you’re one of the more than 30 million postmenopausal women experiencing discomfort due to vulvovaginal atrophy (VVA) then you know just how agonizing vaginal dryness and discomfort during intimacy can be. And for many, the symptoms go beyond the physical – creating an emotional burden as well.
Symptoms of VVA include dryness, soreness, irritation, and vaginal discharge. These symptoms occur as a result of decreased estrogen, leading to the thinning of the vaginal walls. And for many women, this makes sexual intercourse extremely painful.
Due to the sensitive nature of this condition, it can be a taboo topic for women to discuss with their healthcare providers. But for those ready to speak up, there may be a new option. Right now research is underway to determine the safety and effectiveness of an investigational medication in surgically and naturally postmenopausal women experiencing vaginal dryness or discomfort during intimacy. It’s called the Venus 2 Study. And it may be an option for you.
The Venus 2 Study
Surgically and naturally postmenopausal women experiencing vaginal dryness or discomfort during intimacy are invited to find out if they may qualify for a clinical research study to determine the safety and effectiveness of an investigational medication for symptoms caused by vulvovaginal atrophy.
Each woman will be evaluated to determine her eligibility. Among other criteria, women must have had their uterus and/or both ovaries removed of be naturally postmenopausal to qualify. Those who qualify receive study medication or an inactive placebo, study related medical exams, and lab tests at no charge.
Visit Venus2Study.com to learn more.
A special website has been developed to provide more information about the study. The site can help determine if you may qualify to take part in the study, and includes information on what to expect if enrolled. To learn more, visit Venus2Study.com. We also encourage you to talk to your doctor. And if you know someone who is experiencing vaginal dryness or discomfort during intimacy, we encourage you to pass this information along.